Heart failure is a condition in which the heart has lost the ability to pump enough blood to the body’s tissues. With too little blood being delivered, the organs and other tissues do not receive enough oxygen and nutrients to function properly.
NRG1 injection reverses heart-attack damage — Growth factor enhances heart regeneration, improves heart function without need for cardiac stem cells. – Researchers at Children’s Hospital Boston have laid the groundwork for regenerating heart tissue after a heart attack, in patients with heart failure, or in children with congenital heart defects.
Young You Corporation Issues a Voluntary Nationwide Recall of Weight Loss Pills Found to Contain an Undeclared Drug Ingredient – Young You Corporation has been informed by the Food and Drug Administration (FDA) that four weight loss dietary supplements sold and marketed by the firm contain an undeclared drug ingredient.
U.S. Food and Drug Administration (FDA) Approves Sanofi’s Multaq dronedarone to Treat Heart Rhythm Disorders – The U.S. Food and Drug Administration has approved Sanofi’s Multaq tablets (dronedarone) to help maintain normal heart rhythms in patients with a history of atrial fibrillation or atrial flutter (heart rhythm disorders or arrhythmia).
New therapy found to prevent heart failure – Implanted cardiac resynchronization therapy device with defibrillator (CRT-D) reduced a 29 percent reduction in heart failure or death in patients with heart disease, revealed by researchers.
Deaths from heart disease in Canada decreased 30 percent: 10-year national study – Hospital admissions and mortality for heart diseases (cardiovascular disease) declined 30% over a 10-year period in Canada, revealed by canadian researchers.
Certain drug-coated stents may be safe, effective option for elderly patients – Stents coated with the drug paclitaxel may be a safe, effective treatment option for coronary artery disease (CAD) patients age 70 and older and shouldn’t be withheld due to advanced patient age, according to a study reported in Circulation: Cardiovascular Interventions.
Large, long-term study shows Avandia has no increased overall cardiovascular risk compared to other commonly used diabetes medicines – Clinical trial results presented at the American Diabetes Association annual meeting show that overall rates of cardiovascular hospitalization and cardiovascular death are similar in patients taking Avandia (rosiglitazone) compared to those receiving metformin and sulfonylurea.
Rolofylline Did Not Demonstrate Efficacy for Acute Heart Failure in Clinical Trial – Merck’s experimental heart failure drug rolofylline failed to meet the goals in a clinical trial, failing to improve patients. Merck won’t seek approval this year for this heart failure drug rolofylline after preliminary results.
Study indicates that a common virus could cause high blood pressure – Cytomegalovirus affects majority of adults worldwide. – A new study suggests for the first time that cytomegalovirus (CMV), a common viral infection affecting between 60 and 99 percent of adults worldwide, is a cause of high blood pressure, a leading risk factor for heart disease, stroke and kidney disease.
Diet prescribed to lower blood pressure also reduces women’s risk of heart failure. – The DASH diet was initially developed to help patients lower their blood pressure, but a large study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) demonstrates that women who followed the diet also significantly reduced their risk of developing heart failure.
Influenza of all types can pose greater dangers for people with heart failure, or with any cardiovascular disease. – In general, influenza of all types can pose greater dangers for people with heart failure, or with any cardiovascular disease. Like seasonal flu, swine flu may cause a worsening of underlying chronic medical conditions.
Women Live Longer, Not Better, Largely Because of Obesity and Arthritis – Obesity and arthritis that take root during early and middle age significantly contribute to women’s decreased quality of life during their senior years, according to researchers at Duke University Medical Center.
